Pipeline growth delayed; margins compressed mid-execution
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Missed revenue (−7.8% vs +20-25%) and PAT (−33.7% vs +18-19% target) guidance; EBITDA margin lowered 200 bps mid-year.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered a soft quarter with -7.8% revenue and -33.7% PAT declines, and EBITDA guidance was cut from 27-28% to 25-26%. However, the ₹12,800 Cr development pipeline and redevelopment tailwind offer multi-year upside if execution delivers. Key risk: margin pressure persists and ₹3,000 Cr launch execution is untested at this scale.
₹147 Cr
Revenue · −7.8% YoY₹19.1 Cr
Reported PAT · −33.7% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Steady operational performance with healthy customer demand
MISSRevenue down 7.8% YoY; PAT down 33.7% YoY
Gross margins remain resilient at 29.1%
METGross margins at 29.1%, confirmed; but EBITDA margin at 18.9% vs historical 26-27%
EBITDA margins normalise to 25-26% going forward
OVERSTATEDPrior guidance was 27-28%; current guidance of 25-26% is a reduction
Pipeline of ₹12,800 Cr provides visibility for growth
OVERSTATEDPipeline confirmed at ₹12,800 Cr across 4.2M sqft; but FY27 pre-sales guidance of ₹1,000 Cr implies only 8% implied growth
Pre-sales up 9% YoY to ₹155 Cr reflecting customer confidence
PartialPre-sales up 9% YoY; but guidance was 20-25% revenue growth, so 9% pre-sales growth is soft
Earnings quality
What changed since the last call
EBITDA margin guidance cut
DowngradePrior 27-28% target → now targeting 25-26% for FY27. Management attributes to employee cost expansion (213→277 headcount, +30%) and lower investment income. Acknowledged cost inflation absorption challenge.
FY27 revenue growth decelerated
DowngradeQ1 actual revenue ₹147 Cr down 7.8% YoY vs prior 20-25% growth guidance. Pre-sales up only 9% YoY, signalling soft near-term momentum.
Launch pipeline accelerated
UpgradeDevelopment pipeline now ₹12,800 Cr (up from ₹12,000 Cr prior). FY27 launch plan ₹3,000 Cr (2x historical ₹1,500 Cr), with ₹5,000+ Cr planned for FY28.
Leverage remains minimal
NeutralNet debt only ₹5 Cr, net debt-to-equity 0.01x. Unchanged; provides flexibility for construction finance, not equity raises.
The Q&A
Analysts pressed hard on margin compression (Dhananjay: 26-27% → <20%, why?). Samshet held firm at 25-26% target, blaming employee costs and investment income. Kedar questioned Anand Nagar delay (FY29 vs earlier expectations); Amit explained wireless station relocation blocking approvals until FY27-FY28. Gaurav queried why ₹3,000 Cr launches yield only ₹500 Cr FY27 pre-sales; Amit justified conservatism (launches Q3-Q4 don't yield full-year sales). Management composed but defensive on execution risks.
Margin guidance, FY27 pre-sales — Dhananjay Mishra, Centrum Broking
PartialGross margin stable at 29%. EBITDA decline due to lower other income and higher employee costs. We expect to maintain EBITDA margin of 25-26% over the year.
Anand Nagar project timeline — Kedar, NAN Partners
AnsweredNo delays. Wireless station in Dahisar currently restricts building approvals due to height limits. Station shifting to Madh Marve expected FY27, approvals FY28, launch FY29. MOU already signed with society.
Accelerated growth quantification — Sahil Patani, Strokes Capital
AnsweredShift from ₹1,500 Cr to ₹3,000 Cr launches is 100% growth. Next year ₹5,000+ Cr launches planned. These are spikes in growth.
Launch pipeline readiness, delays — Rohit, Individual Investor
AnsweredProjects at various stages. BD starts, then approval, then launch, then construction. Q3: Malad redevelopment ₹750 Cr. Q4: Thane ₹2,000 Cr. Santa Cruz already launched. Combined ₹3,000 Cr potential.
Construction cost inflation, funding needs — Rahul Shah, Eternal Capital
AnsweredConstruction cost inflation absorbed by incremental unit prices, balances out. Outright projects already paid for. Near net-debt currently. May opt for construction finance at lower rates if needed.
Land acquisition cost discipline — Soham Joshi, Individual Investor
PartialVery disciplined in acquisition. Don't do fancy acquisitions, focus on value transactions with healthy margins. Each manager has clear role (redevelopment, outright, JDAs).
FY27 pre-sales outlook vs launches — Gaurav Patil, Individual Investor
Answered₹3,000 Cr completes over 4 years = ₹750 Cr/year avg. Historically ~20% sales upon launch = ₹600 Cr, conservatively ₹500 Cr. Q3-Q4 launches don't yield full-year benefit.
Demand sustainability, redevelopment outlook — Pranav, Individual Investor
AnsweredPresent only in mature, established markets (e.g. not SRA/weaker segments). Aspiring segment focus. Redevelopment will be higher due to land scarcity in MMR and abundance of older buildings.
Guidance
FY27 pre-sales ₹1,000 Cr (₹500 Cr new launches, ₹500 Cr ongoing)
Medium₹3,000 Cr launches planned Q3-Q4 expected to yield ~₹750 Cr/year on 4-year completion cycle. Q3-Q4 partial-year sales conservatively pegged at ₹500 Cr. Dependent on successful launch execution.
FY28 ₹5,000+ Cr launches planned
MediumIncludes Filmistan and 2 additional major projects. Full-year benefit should drive higher pre-sales, but Filmistan approval/execution timeline not confirmed. Macro dependent.
EBITDA margin target 25-26% for FY27 (down from 27-28% prior)
LowCurrent Q1 EBITDA margin 18.9% due to employee cost spike (213→277 headcount, +30%) and lower investment income. Management attributes to temporary factors but provides no timeline for normalization. Risk of further compression if employee costs remain sticky.
PAT margin 18-19% (as per prior target, now unquantified)
LowQ1 PAT margin 13% vs 18-19% target. Management did not re-confirm PAT margin guidance this call. Margin recovery dependent on scaling revenues and absorbing employee cost headwind.
Outright projects already paid for; may use construction finance for launches
HighLand acquisitions funded. Construction finance preferred over equity to avoid dilution. Net-debt minimal at ₹5 Cr, flexibility intact.
Risks the call surfaced
Launch execution
High₹3,000 Cr FY27 launches (Malad ₹750 Cr, Thane ₹2,000 Cr) are 2x historical scale. Coordination, approvals, and construction ramp-up untested. Delays would compress FY27 pre-sales materially.
Margin compression
HighEBITDA margin at 18.9% vs 26-27% historical; guidance cut to 25-26%. Employee costs spiked 30% (213→277 headcount). Fixed-cost absorption lag could persist if revenue growth remains soft.
Pre-sales momentum
MediumPre-sales up only 9% YoY (₹155 Cr) vs prior revenue guidance of 20-25% growth. Soft pre-sales momentum suggests FY27 pre-sales target of ₹1,000 Cr may be at risk if new launches underperform.
Approval/regulatory delays
MediumAnand Nagar (top-3 GDV project) delayed to FY29 due to wireless station relocation in Dahisar. Filmistan approval timeline not confirmed. Height-restriction regulatory changes in MMR could impact other projects.
Financing/refinancing
LowLarge-scale launches may require construction finance; interest-rate risk if borrowing costs rise. Currently at net debt ₹5 Cr but leverage could spike during peak construction period.
Management
Score 6/10. Amit Jain articulate on strategy and pipeline but vague on near-term margin recovery timeline. Samshet Shetye transparent on cost drivers (employee, investment income) but defensive when pressed on margin miss. No new forward-margin quantification provided; relies on '25-26%' assertion without path to recovery. Track record mixed: pre-sales up 9% YoY vs 20-25% revenue guidance—significant miss. Gross margins intact but operating expense control weak (employee costs +30% offsetting revenue). Pipeline expanded (₹12,000→₹12,800 Cr) despite soft quarter—positive signal on BD discipline.
1 · Q3 FY27 (Oct-Dec 2026)
Malad redevelopment launch, ₹750 Cr GDV planned
2 · Q4 FY27 (Jan-Mar 2027)
Thane project launch, ₹2,000 Cr sale potential; total Q3-Q4 ₹3,000 Cr launches
3 · FY28
Filmistan and 2 additional large projects planned; ₹5,000+ Cr launch pipeline
Key risk: margin pressure persists and ₹3,000 Cr launch execution is untested at this scale.
Informational and educational content only. Not investment advice.